{
    "2020-04-21": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly",
                "features": {
                    "keywords": [
                        "Q1",
                        "Earnings",
                        "Scorecard",
                        "Exxon",
                        "Oracle",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "IMBRUVICA® (ibrutinib) Receives 11th FDA Approval",
                "features": {
                    "keywords": [
                        "IMBRUVICA",
                        "ibrutinib",
                        "FDA",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Allergan’s Acquisition by AbbVie Will Close Soon. Why One Analyst Just Downgraded Its Stock.",
                "features": {
                    "keywords": [
                        "Allergan",
                        "AbbVie",
                        "Acquisition",
                        "Downgraded",
                        "Stock"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "8 Safe High-Yield Dividend Stocks Offering 5% or More",
                "features": {
                    "keywords": [
                        "Safe",
                        "High-Yield",
                        "Dividend",
                        "Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Form 8.3 - ABBVIE PLC",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "ABBVIE",
                        "PLC"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Stock Falls 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Falls"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie - A Top Choice for a Post-Virus Portfolio",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Top",
                        "Choice",
                        "Post-Virus",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Form 8.3 - AbbVie Inc.",
                "features": {
                    "keywords": [
                        "Form 8.3",
                        "AbbVie",
                        "Inc."
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}